Report Library
View More
Datamonitor Healthcare Respiratory ...
January 18, 2022
Datamonitor Healthcare Oncology Dis...
January 18, 2022
Datamonitor Healthcare Oncology Dis...
January 17, 2022
Datamonitor Healthcare Oncology Dis...
January 13, 2022
Datamonitor Healthcare Oncology Dis...
January 10, 2022
Datamonitor Healthcare Infectious D...
January 10, 2022
Datamonitor Healthcare Infectious D...
January 6, 2022
Datamonitor Healthcare Oncology Dis...
December 24, 2021
Datamonitor Healthcare Oncology Dis...
December 24, 2021
Datamonitor Healthcare I&I Disease ...
December 24, 2021
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 1/17/22 | Sensorion (ALSEN) | Arazasetron for Hearing Loss - General | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/13/22 | AstraZeneca (AZN) | AZD2816 for COVID-19 Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/12/22 | Pfizer (PFE) | Prevnar 20 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/10/22 | Allogene Therapeutics (ALLO) | ALLO-316 for Renal Cell Cancer (RCC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/10/22 | Allogene Therapeutics (ALLO) | ALLO-501A for Non-Hodgkin's Lymphoma (NHL) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 01/17/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
| 01/17/22 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 01/17/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
| 01/17/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
| 01/17/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
